SAN CARLOS, Calif.--(BUSINESS WIRE)--Alvine Pharmaceuticals, Inc., a privately held biopharmaceutical company focused on developing therapeutic products for the treatment of celiac disease, today announced three new additions to the company’s senior management team. Kirk Essenmacher, M.D., joins Alvine as Vice President of Marketing, Corporate and Strategic Development; Henk Kocken, Ph.D., as Vice President of Quality and Regulatory Affairs; and Revati Shreeniwas, M.D., as Vice President of Clinical Research and Development.
